Skip to main content
Equibles

UBS Group AG

Position in IMNN — Imunon, Inc.

CIK 1610520 ZURICH, V8
Back to IMNN Full portfolio

Position in IMNN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,260
+$7,572 QoQ
Shares Held
5,203
+804.9% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 23 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMNN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. IMNN ranks #449 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in IMNN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,260 5,203
2026-03-31 $1,688 575
2025-12-31 $6,082 1,597
2025-09-30 $55,423 10,804
2025-06-30 $12,269 15,339
2025-03-31 $23 22
2024-12-31 $19 22
2024-09-30 $22 21
2024-06-30 $15,052 12,977
2024-03-31 $34 21
2023-12-31 $4,008 5,896
2023-09-30 $20 21
2023-06-30 $336 261
2023-03-31 $1,925 1,553
2022-12-31 $1,181 876
2022-09-30 $403 240
2022-06-30 $441 240
2022-03-31 $1,396 276